Trial Condition(s):

Prevention of venous thromboembolism after MOS

BAY59-7939, Characterization of oral solution

Bayer Identifier:

14022

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2009-014379-39

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
17
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Xarelto (Rivaroxaban, BAY59-7939)
Accepts Healthy Volunteers
N/A

Where to Participate

Loading...
Locations
Locations
Locations

Bayer HealthCare

Wuppertal, Germany, 42096

For details, please refer to trial results

Additional Information